Nov 7, 2018 Quanterix Expanding Transformative Biomarker Technology Portfolio Into Oncology Quanterix Expanding Transformative Biomarker Technology Portfolio Into OncologyThe technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation ... read morePublished on 2018-11-07